# A Trial of Efficacy and Safety of Remimazolam Tosilate for Injection in Local Anesthesia Assisted Sedation

> **NCT05015361** · PHASE2 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 108 (actual)

## Conditions studied

- Local Anesthesia Assisted Sedation

## Interventions

- **DRUG:** Remimazolam Tosilate
- **DRUG:** Propofol Injection.

## Key facts

- **NCT ID:** NCT05015361
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-07
- **Primary completion:** 2021-06-18
- **Final completion:** 2021-07-04
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2021-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05015361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05015361, "A Trial of Efficacy and Safety of Remimazolam Tosilate for Injection in Local Anesthesia Assisted Sedation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05015361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*